<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The optimal management of intramucosal <z:mp ids='MP_0002038'>carcinoma</z:mp> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> continues to be controversial </plain></SENT>
<SENT sid="1" pm="."><plain>To date, there has not been a lot of research directly comparing endoscopic versus surgical management of intramucosal <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Previous studies have shown that both modalities to have excellent outcomes </plain></SENT>
<SENT sid="3" pm="."><plain>The reviewed article is a matched retrospective cohort study from two high-volume centers, which shows both modalities to be effective, but an associated higher morbidity rate and risk for procedure-related mortality in the surgical group, and higher recurrence rate in the endoscopic therapy group </plain></SENT>
<SENT sid="4" pm="."><plain>The study is discussed in the context of the current state of knowledge regarding <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and intramucosal <z:mp ids='MP_0002038'>carcinoma</z:mp>, in particular outcomes and limitations of the present study </plain></SENT>
</text></document>